The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer
- PMID: 18474322
- DOI: 10.1016/j.clon.2008.03.010
The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer
Comment in
-
Reply to the editorial on the HiLo trial.Clin Oncol (R Coll Radiol). 2009 Feb;21(1):72. doi: 10.1016/j.clon.2008.10.001. Epub 2008 Nov 7. Clin Oncol (R Coll Radiol). 2009. PMID: 18996000 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
